Backed by market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, wider supply chain intelligence, emerging startup coverage, and detailed product-level insights, The Business Research Company’s 2026 market reports are designed to offer research that is more actionable and strategically valuable than ever.
Research-Grade Proteins Market Value Analysis: What Growth Lies Ahead Over The Forecast Period?
The market size for research-grade proteins has witnessed substantial growth in recent years. This market is forecasted to increase from $1.33 billion in 2025 to $1.61 billion in 2026, at a compound annual growth rate (CAGR) of 20.8%. Historically, this expansion was driven by several factors, including the growth of academic life sciences research, the increasing utilization of proteins in molecular biology experiments, the expansion of biopharmaceutical R&D activities, the availability of recombinant protein expression systems, and rising funding for basic biomedical research.
The research-grade proteins market is anticipated to experience significant expansion in the coming years. It will grow to $3.19 billion in 2030 at a compound annual growth rate (CAGR) of 18.6%. This growth during the forecast period stems from an amplified emphasis on precision medicine research, a heightened demand for protein-based drug targets, advancements in cell and gene therapy studies, broader applications of proteins in structural biology, and pharmaceutical companies increasingly outsourcing their research endeavors. Prominent trends foreseen for this period encompass a surge in demand for high-purity proteins in drug discovery, the increasing deployment of recombinant proteins in cell and molecular biology investigations, wider acceptance of research-grade proteins in immunology and oncology research, the proliferation of protein-based assays and functional studies, and a stronger inclination towards tailored and specific-application proteins.
Get A Free Sample Report With In-Depth Market Insights:
Research-Grade Proteins Market Growth Backed By Core Demand Fundamentals
The increasing volume of clinical trials is anticipated to drive expansion in the research-grade proteins market. Clinical trials are defined as investigative studies that examine the safety and effectiveness of new medical treatments, interventions, or devices when applied to human subjects. The rise in the number of these trials can be attributed to advancements in medical research, the existing burden of various diseases, shifts in regulatory frameworks, growing patient demands, and significant industry investment. Research-grade proteins play a crucial role in clinical trials by serving as indispensable tools for developing biomarkers and assays, identifying drug targets, performing quality control, and establishing reference standards, thereby ensuring the accuracy and reliability of experimental outcomes. For instance, in December 2024, the Association of the British Pharmaceutical Industry (ABPI), a UK-based organization, indicated that the number of pharmaceutical industry trials launched in the UK increased for the second consecutive year, rising from 411 in 2022 to 426 in 2023. Thus, the growing number of clinical trials is a key factor propelling the growth of the research-grade proteins market.
Research-Grade Proteins Market Segment Outlook: Which Categories Are Growing Fastest?
The research-grade proteins market covered in this report is segmented –
1) By Product: Cytokines And Growth Factors, Antibodies, Immune Checkpoint Proteins, Virus Antigens, Enzymes, Recombinant Regulatory Proteins, Hormones, Other Products
2) By Host Cell: Mammalian Cells, Bacterial Cells, Fungi And Yeast, Insect Cells, Other Host Cells
3) By End-Use: Pharmaceutical And Biotechnology Companies, Academic And Research Institute, Other End-Uses
Subsegments:
1) By Cytokines And Growth Factors: Interleukins, Interferons, Colony Stimulating Factors, Erythropoietin, Granulocyte Macrophage Colony-Stimulating Factor
2) By Antibodies: Monoclonal Antibodies, Polyclonal Antibodies, Recombinant Antibodies, Conjugated Antibodies
3) By Immune Checkpoint Proteins: PD-1 Inhibitors, PD-L1 Inhibitors, CTLA-4 Inhibitors
4) By Virus Antigens: HIV Antigens, Hepatitis Antigens, Influenza Antigens, Hepatitis B Antigens
5) By Enzymes: Restriction Enzymes, Proteases, Ligases, Kinases
6) By Recombinant Regulatory Proteins: Transcription Factors, Regulatory Enzymes, Epigenetic Modifiers
7) By Hormones: Insulin, Thyroid Hormones, Growth Hormones, Adrenaline
8) By Other Products: Peptides, Serum Proteins, Antigen-Binding Proteins
Research-Grade Proteins Market Growth Trends Reshaping The Competitive Landscape
Major companies in the research-grade proteins market are concentrating on creating innovative solutions, such as high-purity, animal-origin-free recombinant proteins, to enhance consistency, safety, and performance in advanced cell and gene therapy workflows. These high-purity, animal-origin-free recombinant proteins are laboratory-produced proteins made without any animal-derived components and purified to very high standards, ensuring consistency, safety, and reliability for research and therapeutic applications. For instance, in October 2025, Qkine Ltd., a UK-based manufacturing company, introduced a new range of Cell Therapy Grade recombinant proteins specifically engineered to meet the stringent requirements of cell therapy research, process development, and GMP manufacturing. These high-purity, animal-origin-free proteins feature low endotoxin levels and minimal host cell contaminants, produced using defined manufacturing standards with comprehensive regulatory documentation. Their consistent performance supports smooth scalability from early research to GMP clinical workflows. Designed for advanced applications like CAR-T, iPSC differentiation, and ex vivo gene editing, these regulatory-ready proteins help accelerate therapy development while reducing risks.
Research-Grade Proteins Market Leading Companies And Competitive Benchmarking
Major companies operating in the research-grade proteins market are Thermo Fisher Scientific Inc., Bio-Rad Laboratories Inc., Bio-Techne, Stemcell Technologies Inc., Miltenyi Biotec, GenScript Biotech Corporation, Sino Biological Inc., ACROBiosystems, OriGene Technologies Inc., RayBiotech Inc., Rockland Immunochemicals Inc., Proteintech Group Inc., Novus Biologicals LLC, Active Motif, Aviva Systems Biology Corporation, StressMarq Biosciences Inc., Abnova Corporation, AnaSpec, Biomatik, Prospec-Tany Technogene Ltd., Cusabio Technology LLC, United States Biological, Laurus Bio, Boster Biological Technology, AMS Biotechnology Europe Ltd (AMSBIO)
View The Full Research-Grade Proteins Market Report:
Research-Grade Proteins Market Geographic Landscape: Which Region Dominates Industry Growth?
North America was the largest region in the research-grade proteins market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the research-grade proteins market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
